Assuming treatments is required, the following results were found.

  • #ECTRIMS2019 - Are Injectables Inappropriate for Active Relapsing MS? - Multiple Sclerosis News Today

    held in Stockholm, in which two speakers discussed the benefits and risks of low- versus high-efficacy disease-modifying treatments (DMTs). Gisela Kobelt, PhD, a health economist and president of the European Health Economics Association in France,...

    https://mschristian.org/index.php/blog/ectrims2019-are-injectables-inappropriate-for-active-relapsing-ms-multiple-sclerosis-news-today
  • Rejuvenating brain stem cells may hold key to future MS treatments

    Scientists have found a way to make older brain stem cells in rats more youthful. The discovery could lead to improved treatments for aging-related diseases that degrade the brain and nervous system. Researchers managed to rejuvenate stem cells,...

    https://mschristian.org/index.php/articles/2-uncategorised/8533-rejuvenating-brain-stem-cells-may-hold-key-to-future-ms-treatments
  • #ECTRIMS2019 - Are Injectables Inappropriate for Active Relapsing MS? - Multiple Sclerosis News Today

    held in Stockholm, in which two speakers discussed the benefits and risks of low- versus high-efficacy disease-modifying treatments (DMTs). Gisela Kobelt, PhD, a health economist and president of the European Health Economics Association in France,...

    https://mschristian.org/index.php/articles/2-uncategorised/8956-ectrims2019-are-injectables-inappropriate-for-active-relapsing-ms-multiple-sclerosis-news-today
  • Multiple sclerosis treatments delay progression of the disease

    An international study finds multiple sclerosis treatments have long-term benefits, and that early treatment is important. The Royal Melbourne Hospital and University of Melbourne-led study is the first to provide evidence that the currently available...

    https://mschristian.org/index.php/articles/2-uncategorised/5282-multiple-sclerosis-treatments-delay-progression-of-the-disease
  • Infusion Treatments: Benefits and Side Effects

    your nerves. Then it may start to harm the nerves themselves. There’s no cure for MS, but there are several types of treatments. In some cases, treatment can slow the pace of MS. Treatment can also help ease symptoms and reduce potential damage done by...

    https://mschristian.org/index.php/blog/infusion-treatments-benefits-and-side-effects
  • Management of Relapses in MS

    loss. Sensation abnormalities which are very painful or involve difficulty using a limb may also benefit. The usual treatments for relapses, often called exacerbations, of these illness requires very high doses of corticosteroids for a few days. These...

    https://mschristian.org/index.php/management-of-relapses-in-ms
  • What causes numbness in the thigh?

    nerves themselves, there are many potential causes of numbness in the thigh. Depending on the cause, there are also many treatments available. This article will cover some common underlying causes of numbness in one or both thighs. We also discuss...

    https://mschristian.org/index.php/articles/2-uncategorised/8625-what-causes-numbness-in-the-thigh
  • NIH trial aims to improve drug discovery for ischemic stroke

    a nationwide preclinical trial platform called the Stroke Preclinical Assessment Network (SPAN) to ensure candidate new treatments for acute ischemic stroke are tested systematically and efficiently in rodents. The NIH is calling on researchers to make...

    https://mschristian.org/index.php/blog/nih-trial-aims-to-improve-drug-discovery-for-ischemic-stroke
  • Dr Daniel Kantor Highlights MS Treatments and What Is in the Pipeline

    Sept 2019 The field of treatments for multiple sclerosis (MS) has grown quickly in the last 30 years, but the next new class of therapies probably won’t come to market for at least another year and a half, said Daniel Kantor, MD, president of Kantor...

    https://mschristian.org/index.php/articles/2-uncategorised/8972-dr-daniel-kantor-highlights-ms-treatments-and-what-is-in-the-pipeline
  • SLU researcher honored for finding better pain treatments

    named a Fellow of the National Academy of Inventors (NAI) for her contributions toward understanding and finding better treatments for pain. Fellows of the NAI are academic inventors who have made a significant difference in the quality of life in...

    https://mschristian.org/index.php/articles/2-uncategorised/9644-slu-researcher-honored-for-finding-better-pain-treatments
  • What to know about optic neuritis and MS

    neuritis. Although the symptoms of optic neuritis tend to subside over time, some people may also benefit from various treatments. Visual disturbances are among the most common symptom that people with MS have. One study found that optic neuritis is the...

    https://mschristian.org/index.php/blog/what-to-know-about-optic-neuritis-and-ms
  • What to know about MS in children

    difficulties in performing daily tasks and can greatly affect a person's quality of life. There is no cure, and treatments focus on preventing and reducing MS symptoms. MS is not as common in children as it is in adults. When it does develop in...

    https://mschristian.org/index.php/blog/what-to-know-about-ms-in-children-1
  • Rejuvenating brain stem cells may hold key to future MS treatments

    Scientists have found a way to make older brain stem cells in rats more youthful. The discovery could lead to improved treatments for aging-related diseases that degrade the brain and nervous system. Researchers managed to rejuvenate stem cells,...

    https://mschristian.org/index.php/blog/rejuvenating-brain-stem-cells-may-hold-key-to-future-ms-treatments
  • NIH trial aims to improve drug discovery for ischemic stroke

    a nationwide preclinical trial platform called the Stroke Preclinical Assessment Network (SPAN) to ensure candidate new treatments for acute ischemic stroke are tested systematically and efficiently in rodents. The NIH is calling on researchers to make...

    https://mschristian.org/index.php/articles/2-uncategorised/8454-nih-trial-aims-to-improve-drug-discovery-for-ischemic-stroke
  • A Cheap Biotech Stock Tests a Novel Treatment for Multiple Sclerosis - Barron's

    showed hints of actually improving the condition of MS patients, instead of just slowing the disease like most available treatments. If subsequent trials over the next few years confirm the treatment’s effectiveness, Atara could enter the market for MS...

    https://mschristian.org/index.php/blog/a-cheap-biotech-stock-tests-a-novel-treatment-for-multiple-sclerosis-barron-s
  • Society-Funded Investigators Discover New Avenues for Developing Treatments for Progressive MS

    August 13, 2019 These results may help direct the development of new treatments aimed at these brain lesions to stop MS progression. The team is led by Daniel Reich, MD, PhD, and includes Martina Absinta, MD, PhD, who is funded by a postdoctoral...

    https://mschristian.org/index.php/blog/society-funded-investigators-discover-new-avenues-for-developing-treatments-for-progressive-ms
  • What to know about optic neuritis and MS

    neuritis. Although the symptoms of optic neuritis tend to subside over time, some people may also benefit from various treatments. Visual disturbances are among the most common symptom that people with MS have. One study found that optic neuritis is the...

    https://mschristian.org/index.php/articles/2-uncategorised/7784-what-to-know-about-optic-neuritis-and-ms
  • Tanezumab: A Win as Last-Ditch Osteoarthritis Tx

    road. Among 849 patients enrolled from 104 sites from 2016 to 2018 who had not responded to other oral or injectable treatments, those randomized to 5-mg tanezumab had a change on the Western Ontario and McMaster Universities Osteoarthritis (WOMAC) pain...

    https://mschristian.org/index.php/blog/tanezumab-a-win-as-last-ditch-osteoarthritis-tx
  • CMSC INforMS: Use of DMTs Changing ‘Natural History’ of Relapsing MS, Study Says

    sclerosis (MS) have a better prognosis and a slower progression to disability since the introduction of disease-modifying treatments (DMTs) some 20 years ago, according to a retrospective study. The study, “Outcomes in a Modern Cohort of Treated...

    https://mschristian.org/index.php/blog/cmsc-informs-use-of-dmts-changing-natural-history-of-relapsing-ms-study-says
  • Study sheds light on brain cell changes in people with MS

    the study found. The findings could shed new light on how the disease progresses and could also help scientists develop treatments. Experts from the University of Edinburgh and the Karolinska Institute in Sweden analysed post-mortem brain samples from...

    https://mschristian.org/index.php/blog/study-sheds-light-on-brain-cell-changes-in-people-with-ms

Results 1 - 20 of 170